Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our opinions or reviews. Learn how we make money.

How to buy HealthEquity stock | 52.05

Own HealthEquity stock in just a few minutes.

Posted

Fact checked

HealthEquity, Inc is a health information services business based in the US. HealthEquity shares (HQY) are listed on the NASDAQ and all prices are listed in US Dollars. HealthEquity employs 2,931 staff and has a trailing 12-month revenue of around USD$724.4 million.

How to buy shares in HealthEquity

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for HealthEquity. Find the stock by name or ticker symbol: HQY. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until HealthEquity reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At last close price of USD$52.05, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of HealthEquity, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of HealthEquity. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

How has coronavirus impacted HealthEquity's share price?

Since the stock market crash in March caused by coronavirus, HealthEquity's share price has had significant negative movement.

Its last market close was USD$52.05, which is 40.67% down on its pre-crash value of USD$87.73 and 51.31% up on the lowest point reached during the March crash when the shares fell as low as USD$34.4.

If you had bought USD$1,000 worth of HealthEquity shares at the start of February 2020, those shares would have been worth USD$624.34 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth USD$775.02.

HealthEquity share price

Use our graph to track the performance of HQY stocks over time.

HealthEquity shares at a glance

Information last updated 2020-10-14.
Latest market closeUSD$52.05
52-week rangeUSD$34.4 - USD$88.78
50-day moving average USD$53.6029
200-day moving average USD$54.994
Wall St. target priceUSD$66.17
PE ratio 107.1897
Dividend yield N/A (0%)
Earnings per share (TTM) USD$0.798

Compare trading platforms

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee
Vanguard
$0
Stocks, Mutual funds, ETFs, Forex
$1
$20 per year
Get a personal advisor when you open an account with at least $50,000.
Robinhood
$0
Stocks, Options, ETFs, Cryptocurrency
$0
0%
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Sofi Invest
$0
Stocks
N/A
0%
A free way to invest in stocks, ETFs and crypto.
Tastyworks
$0
Stocks, Options, ETFs, Futures
Stocks & ETFs: $1/contract to open, $0 to close, $10 max/leg
Futures: $2.50/contract to open, $0 to close
0%
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
Interactive Brokers
$0
Stocks, Bonds, Options, Mutual funds, Index funds, ETFs, Futures, Cash
$0 + $0.65/contract, $1 minimum
0%
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
TD Ameritrade
$0
or $25 broker-assisted
Stocks
$0 + $0.65/contract,
or $25 broker-assisted
TD Ameritrade features $0 commission for online stock, but watch out for high short-term ETF and broker-assisted trading fees.
loading

Compare up to 4 providers

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy HealthEquity stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

HealthEquity price performance over time

Historical closes compared with the close of $52.05 from 2020-10-19

1 week (2020-10-21) -2.07%
1 month (2020-10-01) 0.37%
3 months (2020-07-29) -3.16%
6 months (2020-04-29) -13.15%
1 year (2019-10-29) -13.18%
2 years (2018-10-29) -38.71%
3 years (2017-10-27) 4.56%
5 years (2015-10-29) 56.45%

Is HealthEquity under- or over-valued?

Valuing HealthEquity stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of HealthEquity's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

HealthEquity's P/E ratio

HealthEquity's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 107x. In other words, HealthEquity shares trade at around 107x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

HealthEquity's PEG ratio

HealthEquity's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.0636. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into HealthEquity's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

HealthEquity's EBITDA

HealthEquity's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$202.8 million.

The EBITDA is a measure of a HealthEquity's overall financial performance and is widely used to measure a its profitability.

HealthEquity financials

Revenue TTM USD$724.4 million
Operating margin TTM 13.95%
Gross profit TTM USD$325.9 million
Return on assets TTM 3.36%
Return on equity TTM -1.68%
Profit margin -2.74%
Book value $17.436
Market capitalisation USD$4.3 billion

TTM: trailing 12 months

Shorting HealthEquity shares

There are currently 5.6 million HealthEquity shares held short by investors – that's known as HealthEquity's "short interest". This figure is 3.5% up from 5.4 million last month.

There are a few different ways that this level of interest in shorting HealthEquity shares can be evaluated.

HealthEquity's "short interest ratio" (SIR)

HealthEquity's "short interest ratio" (SIR) is the quantity of HealthEquity shares currently shorted divided by the average quantity of HealthEquity shares traded daily (recently around 1.0 million). HealthEquity's SIR currently stands at 5.6. In other words for every 100,000 HealthEquity shares traded daily on the market, roughly 5600 shares are currently held short.

However HealthEquity's short interest can also be evaluated against the total number of HealthEquity shares, or, against the total number of tradable HealthEquity shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case HealthEquity's short interest could be expressed as 0.07% of the outstanding shares (for every 100,000 HealthEquity shares in existence, roughly 70 shares are currently held short) or 0.0852% of the tradable shares (for every 100,000 tradable HealthEquity shares, roughly 85 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against HealthEquity.

Find out more about how you can short HealthEquity stock.

HealthEquity share dividends

We're not expecting HealthEquity to pay a dividend over the next 12 months.

HealthEquity share price volatility

Over the last 12 months, HealthEquity's shares have ranged in value from as little as $34.4 up to $88.78. A popular way to gauge a stock's volatility is its "beta".

HQY.US volatility(beta: 1.43)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while HealthEquity's is 1.4313. This would suggest that HealthEquity's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

HealthEquity overview

HealthEquity, Inc. providing technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts. It also provides mutual fund investment platform; and online-only automated investment advisory services through Advisor, a Web-based tool. In addition, the company offers flexible spending accounts; health reimbursement arrangements; and Consolidated Omnibus Budget Reconciliation Act continuation services, as well as administers pre-tax commuter benefit programs. It serves through employers; benefits brokers and advisors; and a network of health plans, benefits administrators, benefits brokers and consultants, and retirement plan record-keepers. HealthEquity, Inc. was founded in 2002 and is headquartered in Draper, Utah.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site